ImmunoGen Inc banner
I

ImmunoGen Inc
XETRA:IMU

Watchlist Manager
ImmunoGen Inc
XETRA:IMU
Watchlist
Price: 8.58 EUR Market Closed
Market Cap: €1.7B

Wall Street
Price Targets

IMU Price Targets Summary
ImmunoGen Inc

There are no price targets for IMU.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
ImmunoGen Inc Competitors:
Price Targets
AMSF
Amerisafe Inc
28% Upside
PTCT
PTC Therapeutics Inc
35% Upside
KNSA
Kiniksa Pharmaceuticals Ltd
25% Upside

Revenue
Forecast

7% / Year
Past Growth
75% / Year
Estimated Growth
Estimates Accuracy
10%
Average Beat
7% / Year
Past Growth
75% / Year
Estimated Growth
Estimates Accuracy
10%
Average Beat

For the last 9 years the compound annual growth rate for ImmunoGen Inc's revenue is 7%. The projected CAGR for the next 4 years is 75%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-53%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-53%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IMU's stock price target?
Not Available

IMU doesn't have any price targets made by Wall Street professionals.

What is ImmunoGen Inc's Revenue forecast?
Projected CAGR
75%

For the last 9 years the compound annual growth rate for ImmunoGen Inc's revenue is 7%. The projected CAGR for the next 4 years is 75%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett